Skip to main content
Premium Trial:

Request an Annual Quote

Crohn's & Colitis Foundation Starts DNA Bank

NEW YORK (GenomeWeb News) – The Crohn's & Colitis Foundation said today that it has launched a DNA Data Bank that will serve as a resource for researchers studying Crohn's disease and ulcerative colitis.

Created with funding from The Donald W. Reynolds Foundation, the DNA data bank contains DNA samples and detailed phenotype data covering a large number of patients with these diseases, often referred to as inflammatory bowel disease (IBD).

"Enhancing research into genetic markers and determinants that affect risk for these diseases … is a priority for researchers seeking to understand the underlying disease process in order to improve disease treatment and prevention," CCFA said.

The databank will be available to qualified investigators in the scientific community for studies of genetic markers related to IBD. Researchers may view available phenotype data elements, obtain summaries of the numbers of affected patients, and family or population controls, and submit research proposals to the Data Bank.

Marjorie Merrick, VP of research for CCFA, said in a statement that "genetic research has the potential to advance our understanding of the etiologies and natural histories of the various forms of Crohn's disease and ulcerative colitis. The launch of the DNA Data Bank symbolizes that we are within reach of our long term goal of improving treatment and minimizing the overall impact of Crohn's and colitis."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more